Immunological changes in the MPTP-induced Parkinson's disease mouse model

[1]  F. Rougé-Pont,et al.  Hemispheric asymmetry in the effects of substantia nigra lesioning on lymphocyte reactivity in mice. , 1992, The International journal of neuroscience.

[2]  M. Moal,et al.  Early effects of unilateral lesions of substantia nigra on immune reactivity , 1992, Neuroscience Letters.

[3]  A. Członkowska,et al.  The immunological status in Parkinson's disease. , 1991, Medical laboratory sciences.

[4]  A. Duchemin,et al.  Preproenkephalin mRNA and Methionine‐Enkephalin Increase in Mouse Striatum After 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Treatment , 1991, Journal of neurochemistry.

[5]  J. Langston,et al.  Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra , 1987, Brain Research.

[6]  C. Markham,et al.  Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Behavior, histology, and biochemistry , 1986, Experimental Neurology.

[7]  R. Duvoisin,et al.  Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. , 1984, Science.

[8]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Cunningham,et al.  Further improvements in the plaque technique for detecting single antibody-forming cells. , 1968, Immunology.

[10]  J. Vaughan,et al.  In vitro Cell Migration as a Model for Delayed Hypersensitivity.∗ , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  R. Sandyk.  A tribute to Professor Sidney Weinstein on his 70th birthday. , 1992, The International journal of neuroscience.

[12]  D. Marić,et al.  In vivo modulation of the immune system by enkephalins. , 1990, The International journal of neuroscience.

[13]  J. Kan,et al.  Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice. , 1989, Life sciences.

[14]  T. Roszman,et al.  Modulation of T‐Suppressor cell activity by central nervous system catecholamine depletion , 1987, Journal of neuroscience research.

[15]  W. Markesbery,et al.  Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. , 1986, Immunology.

[16]  R. Marttila,et al.  Immune functions in Parkinson's disease. , 1984, Advances in neurology.

[17]  N. Plotnikoff,et al.  Enkephalins as immunomodulators. , 1983, International journal of immunopharmacology.